
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.69 | 3.78 | 0.09 |
Shares | 93.18 | 93.18 | 0.00 |
Other | 3.13 | 3.30 | 0.17 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.44 | 20.19 |
Price to Book | 4.11 | 3.26 |
Price to Sales | 2.97 | 2.66 |
Price to Cash Flow | 15.55 | 13.80 |
Dividend Yield | 1.04 | 1.88 |
5 Years Earnings Growth | 18.00 | 11.38 |
Name | Net % | Category Average |
---|---|---|
Industrials | 27.53 | 18.91 |
Technology | 20.25 | 19.55 |
Consumer Cyclical | 18.93 | 13.84 |
Healthcare | 13.77 | 11.96 |
Financial Services | 11.50 | 15.83 |
Communication Services | 4.11 | 5.80 |
Basic Materials | 2.12 | 6.39 |
Energy | 1.80 | 2.27 |
Number of long holdings: 38
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Taiwan Semicon | TW0002330008 | 5.25 | 950.00 | +4.63% | |
Novo Nordisk B | DK0062498333 | 4.26 | 459.1 | +0.70% | |
Sea | US81141R1005 | 3.96 | 142.50 | +0.51% | |
Safran | FR0000073272 | 3.89 | 243.40 | +0.04% | |
SAP | DE0007164600 | 3.86 | 267.350 | +0.39% | |
Ferrari NV | NL0011585146 | 3.84 | 466.46 | +0.78% | |
Spotify Tech | LU1778762911 | 3.74 | 637.14 | -1.07% | |
AstraZeneca | GB0009895292 | 3.23 | 10,754.0 | +1.38% | |
Rolls-Royce Holdings | GB00B63H8491 | 3.11 | 784.00 | +2.22% | |
3I Group | GB00B1YW4409 | 3.05 | 4,260.00 | +0.71% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
WCM Focused International Growth In | 737.1M | 5.09 | 3.81 | 8.95 | ||
WCM Focused Global Growth Fund Inst | 699.54M | -2.63 | 10.20 | 12.37 | ||
WCM Focused Global Growth Fund Inve | 29.45M | 6.43 | 11.34 | 14.07 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review